Latest News about ARQT
Recent news which mentions ARQT
From Benzinga
Arcutis' Flagship Psoriasis Treatment Shows Sustained Efficacy, Clearance For Median Of 10 Months
January 17, 2023
Tickers
ARQT
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
October 21, 2022
From Benzinga
Arcutis Shares Gain On Positive Phase 3 Data On Roflumilast Foam In Scalp, Body Psoriasis
September 26, 2022
Tickers
ARQT
From Benzinga
What 4 Analyst Ratings Have To Say About Arcutis Biotherapeutics
September 22, 2022
Tickers
ARQT
From Benzinga
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
September 09, 2022
From Benzinga
Atopic Dermatitis Player Arcutis Scoops Up DucentisBioTherapeutics
September 08, 2022
Tickers
ARQT
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
September 07, 2022
From Benzinga
Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday
September 06, 2022
From Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 23, 2022
From Benzinga
Arcutis Concludes Dosing In Late-Stage Itchy Skin Study, Anticipates Regulatory Submission By Next Year
August 23, 2022
Tickers
ARQT
From Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 04, 2022
From Benzinga
This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday
August 04, 2022
From Benzinga
Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session
August 03, 2022
From Benzinga
From Benzinga
From Benzinga
Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
August 01, 2022
From Benzinga
From Benzinga
Arcutis Gets FDA Nod For Plaque Psoriasis Candidate, Sees Commercial Launch In Mid-August
July 29, 2022
Tickers
ARQT
From Benzinga
From Benzinga
7 Biotech Stocks to Buy for Q3
July 18, 2022
From InvestorPlace
From Benzinga
Could 2023 Be a Breakout Year for This Pharma Stock?
June 22, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.